Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by heparin (Q41216691)

reason for preferred rank

28 September 2017

Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by heparin (English)

1 reference

https://api.crossref.org/works/10.1136/JCP.20.2.152

8 June 2023

Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by haparin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5602506

8 June 2023

1 reference

P. W. Straub

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5602506

8 June 2023

G. Riedler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5602506

8 June 2023

P. G. Frick

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5602506

8 June 2023

language of work or name

English

0 references

publication date

1 March 1967

1 reference

PMC publication ID

473445

full work available at URL

28 September 2017

https://europepmc.org/articles/PMC473445

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5602506

https://europepmc.org/articles/PMC473445?pdf=render

8 June 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5602506

https://syndication.highwire.org/content/doi/10.1136/jcp.20.2.152

8 June 2023

1 reference

https://api.crossref.org/works/10.1136/JCP.20.2.152

Journal of Clinical Pathology

8 June 2023

published in

1 reference

28 September 2017

20

1 reference

28 September 2017

2

1 reference

28 September 2017

152-157

1 reference

The mechanism of clot dissolution by plasmin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473445

Fibrinolysis in myocardial infarction

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473445

The spontaneous proteolytic activity of dog blood.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473445

Proteolytic enzymes in blood.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473445

Dangerous bleeding associated with carcinoma of prostate.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473445

Variation in fibrinolytic activity after acute myocardial infarction and after the administration of oral anticoagulant drugs and intravenous heparin

19 August 2018

1 reference

12 December 2020

[The effects of heparin of fibrinolysis]

1 reference

12 December 2020

Acute hemorrhagic syndrome with hypofibrinogenemia in metastatic cancer

1 reference

12 December 2020

Fibrinolysis in a patient with carcinoma of the prostate

1 reference

12 December 2020

CHRONIC FIBRINOLYSIS IN PROSTATIC CARCINOMA

1 reference

12 December 2020

[Hypofibrinogenenia and fibrinolysis as a cause of hemorrhage in prostate carcinoma]

1 reference

12 December 2020

The effect of heparin on the fibrinolytic activity of streptokinase-activated human plasma

1 reference

12 December 2020

Spontaneous afibrinogenemia in cancer of prostate; report of two cases

1 reference

12 December 2020

EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS

1 reference

12 December 2020

Haemorrhagic diathesis, fibrinolysis and fibrinogenopenia in prostatic cancer. Report of a case

1 reference

12 December 2020

[Morphological studies on the effect of heparin on experimental depositional thrombi]

1 reference

12 December 2020

[Mechanism of thrombin formation in the isolated system.]

1 reference

12 December 2020

INTERACTION OF HEPARIN WITH FIBRINOLYSIS

1 reference

12 December 2020

The fibrinolytic enzyme system in prostatic cancer

1 reference

12 December 2020

Clotting defect in the presence of metastatic carcinoma of prostate; a case report

1 reference

12 December 2020

[Prostatic fibrinolysis syndrome: nature of the proteolytic activity of the prostate]

1 reference

12 December 2020

[Hyperfibrinolysis in prostatic carcinoma]

1 reference

12 December 2020

[Effect of thrombin and heparin on fibrinolysis]

1 reference

12 December 2020

Effect of 6-amino-n-caproic acid (6-ACA) on fibrinolysis and bleeding conditions in prostatic disease

1 reference

12 December 2020

[Cryofibrinogenemia and pathologically increased fibrinolysis a patient with prostate cancer.]

1 reference

12 December 2020

PATHOGENESIS OF FIBRINOLYSIS IN DEFIBRINATION SYNDROME: EFFECT OF HEPARIN ADMINISTRATION

1 reference

12 December 2020

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

12 December 2020

Fibrinolysis in metastatic cancer of the prostate

1 reference

12 December 2020

The effect of heparin on components of the human fibrinolytic system

1 reference

12 December 2020

Prostatic fibrinolysin; study of a case illustrating role in hemorrhagic diathesis of cancer of the prostate

1 reference

12 December 2020

[Hemorrhagic diathesis in prostate carcinoma and its treatment]

1 reference

12 December 2020

Subacute inclusion encephalitis in South Africa

1 reference

12 December 2020

Classification of Proteolytic Enzymes by Means of their Inhibitors

1 reference

12 December 2020

Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon-aminocapproic acid

1 reference

12 December 2020

Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma

1 reference

12 December 2020

[A micro-method of immuno-electrophoresis]

1 reference

12 December 2020

Circulating fibrinolysin in a case of prostatic carcinoma with bony metastases

1 reference

12 December 2020

Inhibition of fibrinolysis by alimentary lipaemia

1 reference

12 December 2020

Hemorrhagic syndrome with fibrinolysis associated with cancer of the prostate

1 reference

12 December 2020

Hemorrhagic diathesis in patients with carcinoma of prostate

1 reference

12 December 2020

Factor 5 deficiency in hemorrhagic diathesis (parahemophilia)

1 reference

12 December 2020

[Thrombelastography, a method for physical analysis of blood coagulation.]

1 reference

12 December 2020

[Clinical aspects of etiology of acquired afibrinogenemia and fibrinogenopenia with hemorrhagic diathesis; report of a new case]

1 reference

12 December 2020

https://api.crossref.org/works/10.1136/JCP.20.2.152

1

63

353

1955

1 reference

The fibrin plate method for estimating fibrinolytic activity

8 June 2023

https://api.crossref.org/works/10.1136/JCP.20.2.152

8

1 reference

The localization of homolgous plasma proteins in the tissues of young human beings as demonstrated with fluorescent antibodies

8 June 2023

https://api.crossref.org/works/10.1136/JCP.20.2.152

25

1 reference

8 June 2023

Identifiers

DOI

10.1136/JCP.20.2.152

1 reference

28 September 2017

1 reference

PMC publication ID

473445

28 September 2017

1 reference

PMC publication ID

473445